Amphotericin B (conventional deoxycholate)
آمفوتریسین B (معمولی، دزوکسیکولات)
🦠 Antiinfectives For Systemic UsePolyene antifungal
Market / country: 🇺🇸 USA
Fungizone (US)
🧮 Dose calculator
Mucormycosis · Regimen source: FDA Amphotericin B · Dosage and Administration
- • Only for progressive, life-threatening fungal infection. Test dose 1 mg over 20–30 min. Start 0.25 mg/kg/day (0.3 if severe and rapidly progressive), increase gradually to 0.5–0.7 mg/kg/day; max 1 mg/kg daily or 1.5 mg/kg on alternate days. Infuse over 2–6 h at 0.1 mg/mL. FDA Amphotericin B · Dosage and Administration
- • Rhinocerebral mucormycosis generally occurs with diabetic ketoacidosis; restoring diabetic control is imperative for treatment to succeed. FDA Amphotericin B · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to amphotericin B, unless the infection is life-threatening and amenable only to amphotericin B. FDA Amphotericin B · Contraindications
Warnings
- • Overdose can be fatal: never exceed 1.5 mg/kg/day; verify the product name (conventional vs liposomal — not interchangeable). Nephrotoxicity, hypokalaemia, infusion reactions. FDA Amphotericin B · WarningsFDA Amphotericin B · Dosage and Administration
Formulations
- 50 mg vial (conventional — NOT liposomal) — powder for injection 🇺🇸 USA FDA Amphotericin B · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Amphotericin B · Pregnancy
“Teratogenic Effects Pregnancy Category B : Reproduction studies in animals have revealed no evidence of harm to the fetus due to amphotericin B for injection.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Amphotericin B · Nursing Mothers
“Because many drugs are excreted in human milk and considering the potential toxicity of amphotericin B, it is prudent to advise a nursing mother to discontinue nursing.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Amphotericin B · Pediatric Use
“Safety and effectiveness in pediatric patients have not been established through adequate and well-controlled studies.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA063206
- DailyMed (FDA label)FDA Amphotericin B
- MedlinePlus (NIH)Amphotericin B InjectionAmphotericin B Lipid Complex Injection
- WHO ATC/DDDJ02AA01
- Darooyab (Iran)Amphotericin-B
🇮🇷 Registered in Iran Darooyab · G-694/Amphotericin-B
Dosage forms with Iranian generic codes, per Darooyab.
- 09765 · AMPHOTERICIN-B 100MG/50ML VIAL · ویال آمفوتریسین بی ۱۰۰ میلیگرم / ۵۰ میلیلیتر
- 00079 · AMPHOTERICIN-B 50MG/20ML VIAL · ویال آمفوتریسین بی ۵۰ میلیگرم / ۲۰ میلیلیتر
- 17094 · AMPHOTERICIN-B LIPOSOMAL VIAL · ویال آمفوتریسین بی لیپوزومال
- 22891 · AMPHOTERICIN B NANOLIPOSOMAL GEL TOPICAL 0.4 % 15 g · ژل موضعی آمفوتریسین B نانولیپوزومال ۰٫۴ درصد ۱۵ گرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Amphotericin B · How SuppliedFDA Amphotericin B · Dosage and AdministrationFDA Amphotericin B · ContraindicationsFDA Amphotericin B · WarningsFDA Amphotericin B · SPL approval / marketing categoryFDA Amphotericin B · PregnancyFDA Amphotericin B · Nursing MothersFDA Amphotericin B · Pediatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-694/Amphotericin-B
- Clinical review⚠ Unverified